Literature DB >> 21822976

Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy.

Mohammad Namdarghanbari1, William Wobig, Susan Krezoski, Niloofar M Tabatabai, David H Petering.   

Abstract

The present paper centers on mammalian metallothionein 1 and 2 in relationship to cell and tissue injury beginning with its reaction with Cd²⁺ and then considering its role in the toxicology and chemotherapy of both metals and non-metal electrophiles and oxidants. Intertwined is a consideration of MTs role in tumor cell Zn²⁺ metabolism. The paper updates and expands on our recent review by Petering et al. (Met Ions Life Sci 5:353-398, 2009).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822976     DOI: 10.1007/s00775-011-0823-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  189 in total

1.  Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein.

Authors:  L L Pearce; R E Gandley; W Han; K Wasserloos; M Stitt; A J Kanai; M K McLaughlin; B R Pitt; E S Levitan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Zinc metabolism in Ehrlich cells: properties of a metallothionein-like zinc-binding protein.

Authors:  A J Kraker; G Krakower; C F Shaw; D H Petering; J S Garvey
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

3.  Involvement of metallothionein (MT) as a biological protective factor against carcinogenesis induced by benzo[a]pyrene (B[a]P).

Authors:  Masaki Takaishi; Akinori Shimada; Junko S Suzuki; Masahiko Satoh; Hisamitsu Nagase
Journal:  J Toxicol Sci       Date:  2010-04       Impact factor: 2.196

4.  Characterization of calf liver Cu,Zn-metallothionein: naturally variable Cu and Zn stoichiometries.

Authors:  P Chen; P Onana; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

5.  Regulation of metallothionein gene expression by oxidative stress and metal ions.

Authors:  G K Andrews
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

6.  Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.

Authors:  J Liu; S S Habeebu; Y Liu; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1998-11       Impact factor: 4.219

Review 7.  Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review).

Authors:  I Müller; D Niethammer; G Bruchelt
Journal:  Int J Mol Med       Date:  1998-02       Impact factor: 4.101

Review 8.  Historical perspectives on cadmium toxicology.

Authors:  Gunnar F Nordberg
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-31       Impact factor: 4.219

9.  BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

Authors:  Manny D Bacolod; Randy Fehdrau; Stewart P Johnson; Nancy S Bullock; Darell D Bigner; Michael Colvin; Henry S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  2008-07-17       Impact factor: 3.333

10.  Dual nanomolar and picomolar Zn(II) binding properties of metallothionein.

Authors:  Artur Krezel; Wolfgang Maret
Journal:  J Am Chem Soc       Date:  2007-08-14       Impact factor: 15.419

View more
  20 in total

Review 1.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

2.  Metallothioneins: chemical and biological challenges.

Authors:  M Vašák
Journal:  J Biol Inorg Chem       Date:  2011-09-09       Impact factor: 3.358

Review 3.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

4.  ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth.

Authors:  Lu Dai; Aiping Bai; Charles D Smith; Paulo C Rodriguez; Fangyou Yu; Zhiqiang Qin
Journal:  Mol Cancer Ther       Date:  2017-09-22       Impact factor: 6.261

5.  Hepatic mobilization of zinc after an experimental surgery, and its relationship with inflammatory cytokines release, and expression of metallothionein and Zip14 transporter.

Authors:  Violeta Aburto-Luna; Samuel Treviño; Gerardo Santos-López; Diana Moroni-González; Oscar Calva-Cruz; Patricia Aguilar-Alonso; Bertha Alicia León-Chávez; Eduardo Brambila
Journal:  Inflamm Res       Date:  2016-10-27       Impact factor: 4.575

6.  Sensor specific imaging of proteomic Zn2+ with zinquin and TSQ after cellular exposure to N-ethylmaleimide.

Authors:  Andrew Nowakowski; David Petering
Journal:  Metallomics       Date:  2012-04-13       Impact factor: 4.526

7.  Toxic metal proteomics: reaction of the mammalian zinc proteome with Cd²⁺.

Authors:  Mohammad Ali Namdarghanbari; Joseph Bertling; Susan Krezoski; David H Petering
Journal:  J Inorg Biochem       Date:  2014-01-25       Impact factor: 4.155

8.  The x-ray absorption spectroscopy model of solvation about sulfur in aqueous L-cysteine.

Authors:  Ritimukta Sarangi; Patrick Frank; Maurizio Benfatto; Silvia Morante; Velia Minicozzi; Britt Hedman; Keith O Hodgson
Journal:  J Chem Phys       Date:  2012-11-28       Impact factor: 3.488

9.  Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins.

Authors:  Aaron A Mehus; Wallace W Muhonen; Scott H Garrett; Seema Somji; Donald A Sens; John B Shabb
Journal:  Mol Cell Proteomics       Date:  2014-02-03       Impact factor: 5.911

10.  The role of metallothionein in oxidative stress.

Authors:  Branislav Ruttkay-Nedecky; Lukas Nejdl; Jaromir Gumulec; Ondrej Zitka; Michal Masarik; Tomas Eckschlager; Marie Stiborova; Vojtech Adam; Rene Kizek
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.